Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Five-Year Outcomes After Coronary Computed Tomography Angiography (From 110,599 Patients in a Danish Nationwide Register-Based Follow-Up Study)

Research output: Contribution to journalJournal articlepeer-review

  1. Training Contemporary levels of cardiopulmonary resuscitation training in Denmark

    Research output: Contribution to journalJournal articlepeer-review

  2. Direct and indirect costs of heart failure in relation to diabetes status - A nationwide study

    Research output: Contribution to journalJournal articlepeer-review

  3. ECG and CT for the detection of left atrial enlargement in hypertensive individuals-a population-based study

    Research output: Contribution to journalJournal articlepeer-review

  • Kristian Kragholm
  • Jeppe Grøndahl Rasmussen
  • Marc Meller Søndergaard
  • Tomas Zaremba
  • Bhupendar Tayal
  • Filip Lyng Lindgren
  • Holger Marquard Sejersen
  • Martin Bødtker Mortensen
  • Bjarne Linde Nørgaard
  • Jesper Møller Jensen
  • Hans Erik Bøtker
  • Christina Byrne
  • Lars Køber
  • Christian Torp-Pedersen
  • Niels Holmark Andersen
  • Peter Søgaard
  • Mamas Mamas
  • Phillip Freeman
View graph of relations

The long-term cardiovascular risk for patients examined with coronary computed tomography angiography (CCTA) to rule out coronary heart disease compared with population controls remains unexplored. A nationwide register-based study including first-time CCTA-examined patients between 2007 and 2017 in Denmark alive 180 days post-CCTA was conducted. We evaluated 5-year outcomes of myocardial infarction (MI) or revascularization and all-cause mortality in 3 distinct CCTA-groups: (1) no post-CCTA preventive pharmacotherapy use (cholesterol-lowering drugs, antiplatelets, or anticoagulants); (2) post-CCTA preventive pharmacotherapy use; and (3) revascularization or MI within 180 days post-CCTA. For each patient group, population controls were matched on age, gender, and calendar year. Absolute risks standardized to the age, gender, selected co-morbidity, and anti-anginal pharmacotherapy distributions of the specific CCTA-examined patients and respective controls were obtained from multivariable Cox regression. Of 110,599 CCTA-examined patients, (1) 48,231 patients were not prescribed preventive pharmacotherapy 180 days post-CCTA; (2) 42,798 patients were prescribed preventive pharmacotherapy within 180 days post-CCTA; and (3) 19,570 patients were diagnosed with MI or revascularized within 180 days post-CCTA. For patient groups 1 to 3 versus respective controls, 5-year MI or revascularization risks were <0.1% versus 2.0%, <0.1% versus 3.8%, and 19.0% versus 2.5%, all p<0.001. Five-year all-cause mortality were 2.8% versus 4.2%, 5.5% versus 8.8%, and 6.7% versus 8.5%, all p <0.001. In conclusion, the 5-year MI or revascularization risk can be considered very low for CCTA-examined patients without ischemic events within 180 days post-CCTA. Conversely, CCTA-examined patients with MI or revascularization events within 180 days post-CCTA have significantly elevated 5-year MI or revascularization risk.

Original languageEnglish
JournalThe American journal of cardiology
Volume176
Pages (from-to)1-7
Number of pages7
ISSN0002-9149
DOIs
Publication statusPublished - 1 Aug 2022

Bibliographical note

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

ID: 78238860